Form D · Biotechnology
Castle Creek Biosciences, Inc.
Exton, PA · CIK 0001756702
Offering snapshot reported Feb 25, 2025 · SEC filing
- Reported sold
- $75M Offering amount: $75M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 24, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 25, 2025 | Initial | $75,000,000 | No comparison | 30 | SEC filing |
| May 2, 2022 | Initial | $112,782,892 | No comparison | 54 | SEC filing |
| Feb 3, 2022 | Initial | $11,850,000 | No comparison | 6 | SEC filing |
| Jul 9, 2021 | Initial | $25,000,000 | No comparison | Not reported | SEC filing |
| Jan 21, 2020 | Initial | $54,602,249 | No comparison | 12 | SEC filing |
| Oct 24, 2018 | Initial | $560,544,226 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.75M
- Finders' fees
- $0
- Form D file number
- 021-539194
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Paragon Health Capital, LLC | 300729 |
Source: Form D, filed Feb 25, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Aronin | Director |
| David Brill | Director |
| Matthew Crabtree | Director |
| Timothy M. Cunniff | Director |
| Michael Derby | Director, Executive |
| Matthew Gantz | Director, Executive |
| Babar Ghias | Executive |
| Antonio Gracias | Director |
| Mark Graf | Director |
| Gregory Mac Michael | Executive |
| W. Bradford Middlekauff | Executive |
| Patrick Morris | Director |
| Darien Parhad | Executive |
| Mary Spellman | Executive |
| Jude Sullivan | Executive |
| Gregory Wujek | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
405 Eagleview Boulevard
Exton, PA, 19341
Exton, PA, 19341